IRF7-deficient MDBK cell based on CRISPR/Cas9 technology for enhancing IBRV replication

Guiyang Ge1, Dongli Li2, Qian Ling3

  • 1College of Animal Science and Technology, Jilin Agricultural University, Changchun, China.

Frontiers in Microbiology
|December 18, 2024
PubMed

Insights

Researchers developed IRF7-deleted MDBK cells to improve infectious bovine rhinotracheitis (IBR) vaccine production. These modified cells enhance bovine alphaherpesvirus-1 (BoAHV-1) replication, enabling the creation of higher-titer vaccines.

Area of Science:

  • Veterinary Virology
  • Cell Biology
  • Immunology

Background:

  • Infectious bovine rhinotracheitis (IBR), caused by bovine alphaherpesvirus-1 (BoAHV-1), is a significant cattle disease managed by vaccination.
  • Madin-Darby bovine kidney (MDBK) cells are crucial for IBR vaccine production but are subject to innate immune gene inhibition of viral replication.

Purpose of the Study:

  • To develop IRF7-deleted MDBK cells to enhance bovine alphaherpesvirus-1 (BoAHV-1) replication.
  • To facilitate the production of high-titer infectious bovine rhinotracheitis (IBR) vaccines.

Main Methods:

  • CRISPR/Cas9 technology was employed to knockout the IRF7 gene in MDBK cells.
  • Virus growth curves, CCK-8 assays, cell scratch assays, and qPCR were used to assess viral replication and gene expression.

Main Results:

  • IRF7 knockout in MDBK cells significantly increased IBRV replication capacity.
  • A notable reduction in type I interferons (IFN-α and IFN-β) expression was observed in IRF7 knockout cells.
  • The IRF7-/- MDBK cell lines demonstrated enhanced production of high-titer IBRV.

Conclusions:

  • IRF7 knockout MDBK cell lines are effective for high-titer IBRV production.
  • This advancement supports the development of more effective inactivated or attenuated IBR vaccines.